Exercise and Monitoring With Post-Hospitalization Muscle Atrophy to Sustain Intrinsic Capacity and Strength
EMPHASIS
BCCMA: Recovery of Aged Muscle After Disuse Atrophy (REMEDY): Exercise and Monitoring With Post-Hospitalization Muscle Atrophy to Sustain Intrinsic Capacity and Strength (EMPHASIS)
1 other identifier
interventional
250
1 country
2
Brief Summary
The aging Veteran population has more frequent inpatient hospitalization than non-Veterans. In addition, older Veterans have an inability to fully recover muscle mass and function after hospital-acquired weakness. The problem of hospital-acquired weakness is greatly increased in at-risk Veteran populations such as those with chronic kidney disease (CKD). The purpose of this collaborative study involving Denver and Baltimore VAMC sites is to improve health through the detection and rehabilitation management of hospital-acquired weakness in those with CKD. The study goals include identifying and monitoring the optimal muscle assessment sites in clinical settings, examining how muscle health impacts length of hospital stay and physical resilience, and determining how home-based and supervised exercise comparatively addresses post-hospitalization physical resilience using performance tests and Veteran feedback.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2025
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2024
CompletedFirst Posted
Study publicly available on registry
September 23, 2024
CompletedStudy Start
First participant enrolled
April 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2029
May 1, 2025
April 1, 2025
3.5 years
September 19, 2024
April 29, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Vastus Lateralis Muscle Thickness
A measure of the Vastus Lateralis muscle will be examined using ultrasound technology to determine the muscle size, quality, and composition. Post-intervention levels will be compared to 6 months after the cessation of the intervention.
4 month, 10 month
Function
The short physical performance battery test is a function measure that utilizes 3 tasks scores 0-4 (total possible score of 12) to determine functional status and lower extremity function. Pre-test scores will be compared to post intervention test scores.
4 month, 10 month
Lower Extremity Strength - Isometric Strength
A measures of maximal isometric muscle strength produced in knee extensor muscles will be assessed with a Biodex device. Post-intervention levels will be compared to 6 months after the cessation of exercise.
4 month, 10 month
Upper Extremity Strength - Grip Strength
A measures of maximal isometric muscle strength produced in upper extremity muscles will be assessed by grip strength. Post-intervention levels will be compared to 6 months after the cessation of exercise.
4 month, 10 month
Secondary Outcomes (3)
Rectus Femoris Muscle Thickness
4 month, 10 month
Bicep Brachii Muscle Thickness
4 month, 10 month
Middle Deltoid Muscle Thickness
4 month, 10 month
Study Arms (2)
Exercise
EXPERIMENTALThe participants will exercise 2 days a week for 16 weeks. The exercises will include 4 movements: squats, shoulder press, seated row, and bicep curl focusing on internal load and contraction velocity.
Usual Care
NO INTERVENTIONParticipants will not have any study intervention visits for usual care.
Interventions
The participants will exercise 2 days a week for 16 weeks. The exercises will include 4 movements: squats, shoulder press, seated row, and bicep curl focusing on internal load and contraction velocity.
Eligibility Criteria
You may qualify if:
- Age \> 55 years
- Diagnosis of stage 3-4 CKD or an eGFR of \<45 mL/min/1.73m2
You may not qualify if:
- Cardiovascular risk: Poorly controlled hypertension (\>160/100)
- Coronary event in past 6 months
- Class III or IV CHF
- symptomatic angina at rest or during exercise
- Syncope in past year, without known resolution of cause
- COPD requiring home oxygen
- Contraindications to resistance training, including history of intracranial or retinal bleeding; Diabetes with active proliferative retinopathy
- History of significant spinal osteoarthritis or spinal stenosis
- Dementia (on medical record review or mini-mental status exam score)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Rocky Mountain Regional VA Medical Center, Aurora, CO
Aurora, Colorado, 80045-7211, United States
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Baltimore, Maryland, 21201, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Harris-Love, DSc MPT BS
Rocky Mountain Regional VA Medical Center, Aurora, CO
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2024
First Posted
September 23, 2024
Study Start
April 11, 2025
Primary Completion (Estimated)
September 30, 2028
Study Completion (Estimated)
September 30, 2029
Last Updated
May 1, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share